Patents by Inventor Marc A. Jensen
Marc A. Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240091924Abstract: An example hydraulic tool includes: a fluid reservoir; a pump; an electric motor; a cylinder; a piston; a first trigger button; a second trigger button; and a controller configured to perform operations comprising: receiving a first signal when the first trigger button is triggered, responsively, causing the electric motor to rotate in a first rotational direction, thereby: (i) causing the pump to provide fluid to the cylinder, and (ii) causing the piston to move in a first linear direction, thereafter, receiving a second signal when the second trigger button is triggered, and responsively to the second signal, causing the electric motor to rotate in a second rotational direction opposite the first rotational direction, thereby: (i) opening a fluid path from the cylinder to the fluid reservoir, and (ii) causing the piston to move in a second linear direction opposite the first linear direction.Type: ApplicationFiled: November 28, 2023Publication date: March 21, 2024Inventors: Eric D. Norquist, James G. Ballard, Kris J. Kanack, Luke J. Skinner, Robert Jensen, Marc S. D'Antuono, Peter Davies
-
Patent number: 11919646Abstract: An aircraft passenger seat is proposed, comprising a structural component, on which a tray table of the aircraft passenger seat is held via a hinge assembly, the tray table being pivotable about a pivot axis of the hinge assembly. According to the invention, a connection assembly for detachably fitting the tray table on the structural component is provided, the connection assembly comprising an adjustment mechanism for adjusting a mounting position for the tray table relative to the structural component, the adjustment mechanism being designed such that the mounting position can be selected from a plurality of different mounting positions for the tray table relative to the structural component.Type: GrantFiled: August 10, 2022Date of Patent: March 5, 2024Assignee: Zim Aircraft Seating GmbHInventors: Alexander Jensen, Marc Dittrich
-
Publication number: 20220387042Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: ApplicationFiled: August 17, 2022Publication date: December 8, 2022Applicant: PULSAR VASCULAR, INC.Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
-
Publication number: 20220346664Abstract: Methods, devices and systems for acquiring information useful to support a patient in implementing and adhering to a medically prescribed therapy plan are provided. The therapy may incorporate biofeedback methods and/or personalized therapy aspects. A method includes steps of receiving, by a receiving device, biometric information associated with an ingestible event marker; analyzing, by a computing device having a microprocessor configured to perform a biometric information analysis, the biometric information; and determining a therapeutic recommendation at least partly on the basis of the analysis and/or integrating biofeedback techniques into patient therapy or activity. A system includes a biometric information module to receive biometric information associated with an ingestible event marker; an analysis module to analyze the biometric information; and a determination module to optionally determine and communicate a therapeutic recommendation at least partly on the basis of the analysis.Type: ApplicationFiled: July 14, 2022Publication date: November 3, 2022Applicant: OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Marc JENSEN, Robert LEICHNER, Patrick BEAULIEU, Kityee AU-YEUNG, Lawrence ARNE, Mark ZDEBLICK, Andrew THOMPSON, George SAVAGE, Timothy ROBERTSON, Yashar BEHZADI
-
Patent number: 11457923Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device can include a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: GrantFiled: August 19, 2019Date of Patent: October 4, 2022Assignee: PULSAR VASCULAR, INC.Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
-
Publication number: 20220151632Abstract: Implants can be used as flow diverters for treating aneurysms. Implants can include a stabilizing frame for anchoring the implant and an occluding element for diverting blood flow from the aneurysm neck. The stabilizing frame can have two parts, the first part sized to anchor within the sac of the aneurysm and the exterior part sized to anchor against a region of the blood vessel wall adjacent the aneurysm neck. The occluding element can be attached to the interior frame and positioned to occlude the aneurysm neck. The implant can have a central node that can be positioned near the center of the aneurysm neck at which the interior frame is attached to the exterior frame and from which the interior frame and the exterior frame extend.Type: ApplicationFiled: February 7, 2022Publication date: May 19, 2022Applicant: DePuy Synthes Products, Inc.Inventors: Michael WALSH, Chad ROUE, Marc JENSEN
-
Patent number: 11272939Abstract: Implants can be used as flow diverters for treating aneurysms. Implants can include a stabilizing frame for anchoring the implant and an occluding element for diverting blood flow from the aneurysm neck. The stabilizing frame can have two parts, the first part sized to anchor within the sac of the aneurysm and the exterior part sized to anchor against a region of the blood vessel wall adjacent the aneurysm neck. The occluding element can be attached to the interior frame and positioned to occlude the aneurysm neck. The implant can have a central node that can be positioned near the center of the aneurysm neck at which the interior frame is attached to the exterior frame and from which the interior frame and the exterior frame extend.Type: GrantFiled: December 18, 2018Date of Patent: March 15, 2022Assignee: DePuy Synthes Products, Inc.Inventors: Michael Walsh, Chad Roue, Marc Jensen
-
Publication number: 20200187952Abstract: Implants can be used as flow diverters for treating aneurysms. Implants can include a stabilizing frame for anchoring the implant and an occluding element for diverting blood flow from the aneurysm neck. The stabilizing frame can have two parts, the first part sized to anchor within the sac of the aneurysm and the exterior part sized to anchor against a region of the blood vessel wall adjacent the aneurysm neck. The occluding element can be attached to the interior frame and positioned to occlude the aneurysm neck. The implant can have a central node that can be positioned near the center of the aneurysm neck at which the interior frame is attached to the exterior frame and from which the interior frame and the exterior frame extend.Type: ApplicationFiled: December 18, 2018Publication date: June 18, 2020Applicant: DePuy Synthes Products, Inc.Inventors: Michael WALSH, Chad ROUE, Marc JENSEN
-
Publication number: 20190365386Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In one example, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device comprises a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The closure structure can include a plurality of struts forming support arms and anchoring arms. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. A barrier can span at least a portion of the distal-facing aspect of the closure structure and be configured to further occlude a neck of the aneurysm. The closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: ApplicationFiled: August 19, 2019Publication date: December 5, 2019Applicant: PULSAR VASCULAR, INC.Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
-
Patent number: 10426487Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: GrantFiled: April 25, 2017Date of Patent: October 1, 2019Assignee: Pulsar Vascular, Inc.Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
-
Publication number: 20180279910Abstract: A system including a sensor, a mobile device, and a computer system is disclosed. The sensor is configured to detect physiologic data from the body of the patient. The mobile device includes a patient data input device. The computer system, communicatively coupled to the mobile device, includes a patient record indicating: patient data comprising a plurality of patient activities, and detected physiological data received from the sensor via the mobile device. The computer system is configured to identify an unhealthy physiological data value from the detected physiological data of the patient record, correlate the unhealthy physiological data value to a patient activity of the patient data, select a therapeutic recommendation to address the unhealthy physiological data value, and transmit the selected therapeutic recommendation to the patient, via the mobile device, at a future time associated with the patient activity correlated to the unhealthy physiological data value.Type: ApplicationFiled: January 25, 2018Publication date: October 4, 2018Inventors: Marc Jensen, Robert Leichner, Patrick Beaulieu, Kit Yee Au-Yeung, Lawrence Arne, Mark Zdeblick, Andrew Thompson, George Savage, Timothy Robertson, Yashar Behzadi
-
Patent number: 9883819Abstract: Methods, devices and systems for acquiring information useful to support a patient in implementing and adhering to a medically prescribed therapy plan are provided. The therapy may incorporate biofeedback methods and/or personalized therapy aspects. A method includes steps of receiving, by a receiving device, biometric information associated with an ingestible event marker; analyzing, by a computing device having a microprocessor configured to perform a biometric information analysis, the biometric information; and determining a therapeutic recommendation at least partly on the basis of the analysis and/or integrating biofeedback techniques into patient therapy or activity. A system includes a biometric information module to receive biometric information associated with an ingestible event marker; an analysis module to analyze the biometric information; and a determination module to optionally determine and communicate a therapeutic recommendation at least partly on the basis of the analysis.Type: GrantFiled: January 6, 2010Date of Patent: February 6, 2018Assignee: Proteus Digital Health, Inc.Inventors: Marc Jensen, Robert Leichner, Patrick Beaulieu, Kit Yee Au-Yeung, Lawrence Arne, Mark Zdeblick, Andrew Thompson, George Savage, Timothy Robertson, Yashar Behzadi
-
Publication number: 20170224353Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: ApplicationFiled: April 25, 2017Publication date: August 10, 2017Applicant: Pulsar Vascular, Inc.Inventors: Anthony BACHMAN, Chad ROUE, Marc JENSEN, Mike WALSH, Scott CAMERON, Michael GENDREAU, Robert M. ABRAMS
-
Patent number: 9636117Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: GrantFiled: July 24, 2015Date of Patent: May 2, 2017Assignee: PULSAR VASCULAR, INC.Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
-
Patent number: 9259229Abstract: The present disclosure describes implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. In particular, selected embodiments of the present technology comprise a coil loop, or tip, on a portion of the implantable device. The coil tip can provide a soft and/or smooth interface with the aneurysm and can provide improved coverage of the neck of the aneurysm.Type: GrantFiled: March 14, 2013Date of Patent: February 16, 2016Assignee: Pulsar Vascular, Inc.Inventors: Robert M. Abrams, Chad Roue, Marc Jensen
-
Publication number: 20150327867Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device comprises a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: ApplicationFiled: July 24, 2015Publication date: November 19, 2015Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
-
Patent number: 9119625Abstract: The present technology is directed generally to devices, systems, and methods for enclosing anatomical openings. In several embodiments, an aneurysm device is endovascularly deliverable to a site proximate to an arterial aneurysm. The aneurysm device includes a closure structure having a distal-facing aspect configured to at least partially occlude the aneurysm and a proximal-facing aspect configured to arch over lumina of an artery. The device further includes a supplemental stabilizer connected to the closure structure and configured to reside in the artery and press outward against a luminal wall thereof. In some embodiments, the device can also include a barrier spanning at least a portion of the distal-facing aspect of the closure structure and configured to further occlude a neck of the aneurysm. In further embodiments, the closure structure can be configured to restrict and/or divert flow to or from the aneurysm.Type: GrantFiled: October 5, 2012Date of Patent: September 1, 2015Assignee: Pulsar Vascular, Inc.Inventors: Anthony Bachman, Chad Roue, Marc Jensen, Mike Walsh, Scott Cameron, Michael Gendreau, Robert M. Abrams
-
Publication number: 20140180202Abstract: An ingestible therapy activator system and method are provided. In one aspect, the ingestible therapy activator includes an ingestible device having an effector module to send an effector instruction and a responder module associated with a therapeutic device. The responder module may receive and process the effector instruction, resulting in a response by the therapeutic device. Examples of responses by therapeutic device include activating a therapy, deactivating a therapy, modulating a therapy, and discontinuing a therapy.Type: ApplicationFiled: February 26, 2014Publication date: June 26, 2014Applicant: Proteus Digital Health, Inc.Inventors: MARK ZDEBLICK, MARC JENSEN, OLIVIER COLLIOU, ANGELA STRAND
-
Patent number: 8738154Abstract: Implantable stimulation devices are provided. Aspects of the devices include a multiplexed multi-electrode component configured for neural stimulation. The multiplexed multi-electrode component includes two or more individually addressable satellite electrode structures electrically coupled to a common conductor. The satellite structures include a hermetically sealed integrated circuit controller operatively coupled to one or more electrodes. Also provided are systems that include the devices of the invention, as well as methods of using the systems and devices in a variety of different applications.Type: GrantFiled: May 24, 2011Date of Patent: May 27, 2014Assignee: Proteus Digital Health, Inc.Inventors: Mark Zdeblick, Todd Thompson, Marc Jensen, Olivier Colliou, Angela Strand
-
Publication number: 20130304109Abstract: The present disclosure describes implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. In particular, selected embodiments of the present technology comprise a coil loop, or tip, on a portion of the implantable device. The coil tip can provide a soft and/or smooth interface with the aneurysm and can provide improved coverage of the neck of the aneurysm.Type: ApplicationFiled: March 14, 2013Publication date: November 14, 2013Inventors: Robert M. Abrams, Chad Roue, Marc Jensen